This collaboration marks a significant stride for Imexpharm, empowering the company to delve deeper into the production of specialised medications at affordable prices, Imexpharm said in a statement.
The recognition demonstrated Imexpharm''s great efforts in creating a happy and sustainable working environment for nearly half a century, the company said in a statement.
The Asian Development Bank (ADB) on Wednesday signed an US$8 million loan deal with Imexpharm Corporation to help the company sustain its production of generic medicines despite global supply disruptions caused by the COVID-19 pandemic.